InnoCare Pharma Limited (SHA:688428)
China
· Delayed Price · Currency is CNY 25.01
-0.21 (-0.83%)
At close: Jul 7, 2025, 2:57 PM CST
InnoCare Pharma Revenue
InnoCare Pharma had revenue of 381.26M CNY in the quarter ending March 31, 2025, with 129.92% growth. This brings the company's revenue in the last twelve months to 1.22B, up 71.32% year-over-year. In the year 2024, InnoCare Pharma had annual revenue of 1.01B with 36.68% growth.
Revenue (ttm)
1.22B
Revenue Growth
+71.32%
P/S Ratio
20.56
Revenue / Employee
1.12M
Employees
1,089
Market Cap
25.18B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |